Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance
Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs
Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation
SEAL Analytical's theme is totally automatic
Reflecting customer demand, Asynt have continued to expand their range of DrySyn heating block systems for reactions in tubes, vials and flasks
Cole-Parmer reveals new compact and cost effective drives for general fluid transfer applications
New liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability
Thermo Scientific ISQ EM system offers a robust, easy-to-use and reliable solution for both novice and expert users
FLIR Systems announces update version 4.40 of its popular thermal measurement, recording and analysis software - ResearchIR
Ground-breaking technology unlocks rapid and simple label-free 3D and 4D live cell imaging
Learn about modern immunoblot imaging technologies that can improve your data quality and save you time
Find out why PROTACs hold such promise in cancer drug discovery
Achieve economical online monitoring of industrial wastewater and more, with Metrohm's new photometer
Experts share information about the latest technology and automation strategies to maximize screening throughput
Organoid expert reveals recent developments, benefits, and challenges in organoid research
Thermo Scientific VetDrugs Explorer Collection provides LC-MS/MS-based solution for multi-class veterinary drug residues in sample matrices
Innovative new sample tubes enable full tracebility, minimize contamination and improve storage effiiency
Determining connections between genetic traits and diseases using genome-wide studies could help improve efficacy and safety of new therapeutic drug
BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio
